CXCR4-Targeted Macrophage-Derived Biomimetic Hybrid Vesicle Nanoplatform for Enhanced Cancer Therapy through Codelivery of Manganese and Doxorubicin
ACS Applied Materials & Interfaces · 10.04.2024 · 16 (14) · 17129-17144
DOI: 10.1021/acsami.3c18569 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 27.03.2024. Verfasst von Yeonwoo Jang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Integrative Engineering, Chung-Ang University, Seoul 06974, Republic of Korea. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoplasms. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDDK NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Integrative Engineering, Chung-Ang University, Seoul 06974, Republic of Korea.
- Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, Michigan 48109, United States.
- Biointerfaces Institute, University of Michigan, Ann Arbor, Michigan 48109, United States.
- Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan 48109, United States.
ORCID-Profile: Yeonwoo Jang, Young Seok Cho, Xingwu Zhou, Yujin Kim, James J Moon, Hansoo Park
Förderung
- NCI NIH HHS
- NIDDK NIH HHS
- NIGMS NIH HHS
- NIBIB NIH HHS
- NIDCR NIH HHS
- NIAID NIH HHS
- National Cancer Institute
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Jang, Y., Cho, Y. S., Kim, A., Zhou, X., Kim, Y., Wan, Z., Moon, J. J., & Park, H. (2024). CXCR4-Targeted Macrophage-Derived Biomimetic Hybrid Vesicle Nanoplatform for Enhanced Cancer Therapy through Codelivery of Manganese and Doxorubicin. ACS Applied Materials & Interfaces, 16(14), 17129-17144. https://doi.org/10.1021/acsami.3c18569
Vancouver
Jang Y, Cho YS, Kim A, Zhou X, Kim Y, Wan Z, et al. CXCR4-Targeted Macrophage-Derived Biomimetic Hybrid Vesicle Nanoplatform for Enhanced Cancer Therapy through Codelivery of Manganese and Doxorubicin. ACS Applied Materials & Interfaces. 2024;16(14):17129-17144. doi:10.1021/acsami.3c18569
BibTeX
@article{Jang2024,
author = {Jang, Yeonwoo and Cho, Young Seok and Kim, April and Zhou, Xingwu and Kim, Yujin and Wan, Ziye and Moon, James J and Park, Hansoo},
title = {CXCR4-Targeted Macrophage-Derived Biomimetic Hybrid Vesicle Nanoplatform for Enhanced Cancer Therapy through Codelivery of Manganese and Doxorubicin},
journal = {ACS Applied Materials & Interfaces},
year = {2024},
volume = {16},
number = {14},
pages = {17129--17144},
doi = {10.1021/acsami.3c18569}
}
EUVIMED